Last $0.42 PHP
Change Today 0.00 / 0.00%
Volume 70.0K
As of 1:47 AM 05/24/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Sigurdur Oli Olafsson

President of Global Generics, Actavis, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 board members in 2 different organizations across 4 different industries.

See Board Relationships
43$4,015,193
As of Fiscal Year 2012

Background*

Mr. Sigurdur Oli Olafsson has been the President of Global Generics at Actavis, Inc. (formerly Watson Pharmaceuticals, Inc) since May 17, 2012. Mr. Olafsson served as Executive Vice President of Global Generics at Actavis, Inc. from September 1, 2010 to May 17, 2012. He served as Chief Executive Officer of Actavis Group from August 2008 to June 23, 2010 and served as its President of US Sales & marketing & Member of the Executive Board until June 23, 2010 and Deputy ...

Read Full Background

Corporate Headquarters*

No. 1, Waterfront Drive
Cebu City, -- 6000

Philippines

Phone: 63 2 232 6888
Fax: --

Board Members Memberships*

Director and President of Actavis Pharma
Director

Education*

Unknown/Other Education
Háskóli Íslands
MS
Háskóli Íslands

Other Affiliations*

Annual Compensation*

Salary$681,674
Total Annual Compensation$681,674

Stock Options*

Restricted Stock Awards$2,568,245
All Other Compensation$38,557

Total Compensation*

Total Annual Cash Compensation$1,446,948
Total Short Term Compensation$681,674
Other Long Term Compensation$2,606,802
Total Calculated Compensation$4,015,193
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WPI:PM $0.42 PHP 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Dilip Shantilal Shanghvi Managing Director, Promoter executive Director and Member of Shareholders/Investors Grievance Committee
Sun Pharmaceutical Industries Limited
--
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$998.1K
Joseph C. Papa Chairman, Chief Executive Officer and President
Perrigo Company
$1.0M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Head of Human Genetic Therapies and Director
Shire plc
--
Frederic Roch Doliveux DVMChief Executive Officer and Executive Director
UCB SA
€1.8M
Compensation as of Fiscal Year --.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WATERFRONT PHILIPPINES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.